INTRODUCTION
Transdermal drug delivery (TDD) is the potential route for delivering systemic drugs. But the greatest challenge is the barrier nature of stratum corneum (Aqil et al., 2007) . Many techniques have been aimed to disrupt or weaken the barrier property of skin. One method is the use of vesicle formulations as skin delivery systems (Honeywell-Nguyen and Bouwstra, 2005) . Intensive research over the past two decades led to the development of novel carriers, the ethanolic liposomes that have been termed ethosomes .
Ethosomes are novel lipid vesicles embodying high concentration (20-45%) of ethanol and are prepared by dissolving the lipids and drug in ethanol . Several studies have reported that ethosomes were able to improve in vitro and in vivo skin delivery of various drugs, both under occlusive and non-occlusive conditions (Prasanthi and Lakshmi, 2012) .
The aim of the present study was to statistically optimize the vesicular formulations (Ethosomes) for enhanced skin delivery of a model drug Alfuzosin hydrochloride (AH), α-adrenoreceptor antagonist used for benign prostatic hyperplasia. It has low oral bioavailability of about 64% and its physicochemical properties like molecular weight (425.9), half-life (3-5), log P value (1.604), and low dose (2.5 to 10 mg/day) makes it an ideal drug candidate for TDD (Martindale, 1993) . AH has been previously identified as a promising candidate for TDD (Prasanthi et al., 2010) .
Taguchi robust design is a statistical technique which studies all levels of input parameters with fewer experiments and optimizes the experiment having least variability. The variability of a property is expressed by signal to noise ratio (S/N Ratio) (Kim et al., 2007) .
In the present study, ethosomes bearing AH was prepared by cold method and optimized by Taguchi
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robust design method. They were evaluated for permeation enhancement over pure drug solution and the optimized formulation was evaluated for vesicle skin interaction studies and stability studies. 
MATERIALS AND METHODS

Preparation of ethosomes
Ethosomal formulations were prepared by the cold method (Verma and Pathak, 2012) using Taguchi robust design. The ethanolic vascular system was composed of phospholipid (2.0% to 4.0% with/Vol), ethanol (20% to 40% Vol/Vol), drug (AH, 0.5% wt/Vol) and double distilled water to 100% (Vol/Vol). Phospholipid was dissolved along with the drug in ethanol. This mixture was heated to 40°C ± 1°C and a fine stream of double-distilled water was added slowly, with constant mixing at 700 rpm with a mechanical stirrer (Remi Instruments, Vasai, India) in a house-built closed container. Mixing was continued for an additional 5 minutes, while maintaining the system at 40°C ± 1°C. The preparation was left to cool at room temperature for 30 min and then it was sonicated at 4°C for five cycles of 3 minutes each with a 1-minute rest between cycles using a probe sonicator (SonicsVibra Cell). Nine formulations were prepared according to Taguchi L9 orthogonal array design shown in Table 2 . Ethosomes were compared with thirty percent of hydroethanolic solution of drug and drug solution in distilled water.
Experimental design
A three-factor, three-level Taguchi L9 orthogonal array experimental design was constructed using MINITAB 16 software (Minitab Inc., PA, U.S.A). The independent variables selected were the type of phospholipid, concentration of phospholipid and concentration of ethanol. Their corresponding levels and the dependent variables are shown in Table1.
Evaluation of ethosomes Vesicular shape and surface morphology
Scanning electron microscopy (SEM) was used to characterize the surface morphology of the prepared vesicles. One drop of ethosomal suspension was mounted on a clear-glass stub, air-dried, gold coated with Polaron E5100 sputter coater (Polaron, United Kingdom), and visualized under scanning electron microscope (Jeol 5400, Japan). 
MATERIAL AND METHOD
Vesicle size and zeta potential
The vesicle size and zeta potential were measured by photon correlation spectroscopy (Delsa Nano, Beckman Coulter Inc. UK).
Entrapment efficiency
Prepared ethosomal vesicles were separated from the free (unentrapped) drug by ultracentrifugation technique (Verma and Pathak, 2012) . 2 ml of the ethosomal suspension was diluted with distilled water up to 5 ml and centrifuged at 20,000 rpm for 45 min at 4 0 C using a cooling centrifuge (Eltek centrifuge). After centrifugation, the supernatant and sediment were recovered, and sediment was lysed using methanol and filtered through a 0.45 µm nylon disk filter. The concentration of AH in the supernatant and sediment was analysed by UV-VIS double beam spectrophotometer (Chemito Spectrascan UV2600, India) at 245nm. The percentage drug entrapment was calculated using the following equation:
%Drug entrapment = Amount of entrapped drug recovered Total amount of drug × 100
The determination of entrapment efficiency was repeated three times per sample at 25°C.
Skin permeation studies
Institutional animal ethical committee (IAEC) approved skin permeation studies. Locally fabricated Keshary Chein diffusion cell was used for permeation studies. Studies were conducted using dermatomed and prepared rat skin. 20 ml of PBS 7.4 was taken in receptor compartment and was continuously stirred with a magnetic stirrer and equilibrated at 37°±1°C with a recirculating water bath. The dermatomed skin was mounted with stratum corneum facing upward into the donor compartment. 1 ml of ethosomal formulation was taken in donor compartment and covered with parafilm to avoid any evaporation process. 1 ml samples were withdrawn through the sampling port at predetermined intervals over 24 hr and analysed for drug content by UV-VIS double beam spectrophotometer (Chemito Spectrascan UV2600, India) at 245nm. Similar studies were performed with hydroethanolic solution and drug solution.
Skin deposition studies
The amount of AH retained in the skin was deter- mined by skin deposition studies. At the end of permeation studies (24hr), the skin was washed 10 times with a cloth immersed in methanol. A sample of skin was weighed and homogenized with methanol for 5 min using an electric stirrer. The resulting solution was centrifuged at 7000 rpm for 10min and supernatant was analysed for drug content by UV-VIS double beam spectrophotometer (Chemito Spectrascan UV2600, India) at 245nm.
Vesicle-skin interaction studies
Interaction studies were studied on the basis of structural changes in stratum corneum, epidermis and dermis . The formulations were applied topically to the dorsal portion of rats for 8hrs. Later, the rats were killed by cervical dislocation; the skin was excised and fixed by immersion in 50% neutral formalin solution in saline for 24hrs. The samples were subjected to histological processing, by dehydration and rehydration with graded alcohols, paraffin block processing and stained with haemotoxyllin-eosin. Microscopic evaluation using dark-light microscope was performed by a blinded assessor.
Stability studies
Vesicles were stored at 4°C± 0.5°C for 120 days. To determine their stability vesicle size, zeta potential and entrapment efficiency of the vesicles was measured using the method described earlier.
Data analysis
All the experiments were performed in triplicate unless specified, and the data are expressed as mean values ± standard deviations. Statistical significance was performed using one-way ANOVA at confidence limit of P<0.05. (MINITAB 16 software (Minitab Inc., PA, U.S.A)).
RESULTS AND DISCUSSION
Ethosomal formulations were prepared by the cold method according to Taguchi L9 orthogonal array design given in Table 2 . On characterization spherical, unilamellar vesicles with smooth surface were observed under scanning electron microscope (Figure 1 ).
Ethosomes were optimized by varying phospholipid type, concentration of phospholipid and concentration of ethanol. Effect of independent variables on dependent variables was evaluated by SN ratio plots (Figure 2 & Figure 3 ). Main effects plot of SN ratios showed phospholipid type had no significant effect on entrapment and flux (P> 0.05).
But maximum permeation was observed with soya phosphatidylcholine as it offers rigidity to the layers thereby reducing vesicle fusion resulting in decreased particle size and better permeation through skin pores.
Concentration of phospholipid (2% to 4%) effected entrapment efficiency and flux. Previous studies reported increases in phospholipid, increased entrapment (Patel and Patel, 2009; Dubey et al., 2010) . From the SN ratios plot it has been observed entrapment efficiency and flux increased with increase in phospholipid concentration up to 3%, but further increase decreased entrapment efficiency Permeation studies were performed using a rat abdominal skin. Figure 4 . The results are given in Table 3 .
When compared to drug solution and hydroethanolic solution ethosomes showed better permeation due to the synergistic effect of phospholipids and ethanol as phospholipids in the vesicles entrap hydrophilic/lipophilic drug molecules act as carriers and deliver the entrapped drugs into or across the skin. Ethanol enhances permeation by various mechanisms such as push and pull effect, fluidization of stratum corneum lipids and vesicular lipid bilayers providing malleability to vesicles to penetrate skin pores smaller than their diameter (Panchagnula et al., 2001; Kowatsu and Okada, 1996) .
Vesicle-skin interaction studies ( Figure 5 ) did not exhibit any major alterations except the slight fatty change in dermis revealing a decrease in resistance of skin as a barrier by fluidization of lipids, by ethanol. Stability studies performed at 4°C ± 1°C for 120 days showed good storage stability (Table 4 ) (Dubey et al., 2007) .
CONCLUSION
Soft malleable vesicles consisting of phospholipids and higher concentration of ethanol exhibited synergistic effect of phospholipids and ethanol on permeation proving elastic liposomes (ethosomes) are better carriers for Alfuzosin hydrochloride transdermal delivery. 
